Search Results (53)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome. | Academic Article |
Why?
|
| Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review. | Academic Article |
Why?
|
| Clinical Features and Treatment of Down Syndrome Arthropathy: Experience from Two US Tertiary Hospitals. | Academic Article |
Why?
|
| Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study. | Academic Article |
Why?
|
| Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes. | Academic Article |
Why?
|
| Immune-related conditions and acute leukemia in children with Down syndrome: a Children's Oncology Group report. | Academic Article |
Why?
|
| Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. | Academic Article |
Why?
|
| Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. | Academic Article |
Why?
|
| Resting energy expenditure in adolescents with Down syndrome: a comparison of commonly used predictive equations. | Academic Article |
Why?
|
| Tracheostomy in the pediatric trisomy 21 population. | Academic Article |
Why?
|
| Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder. | Academic Article |
Why?
|
| Gamis, Alan | Person |
Why?
|
| Treatment Decisions for Babies with Trisomy 13 and 18. | Academic Article |
Why?
|
| Infant With Trisomy 18 and Hypoplastic Left Heart Syndrome. | Academic Article |
Why?
|
| Trisomy 13 and 18--Treatment Decisions in a Stable Gray Zone. | Academic Article |
Why?
|